Sifat Jubaira: When Low MCV Meets High Platelets
Sifat Jubaira, Lab Medicine Specialist at United Hospital Limited, shared a post on LinkedIn:
”High Platelets (typically quote 450,000/µL) plus Low MCV – Think Iron Deficiency Anemia.
Seen in 30 percent cases of IDA.
Quick CBC pearl:
- Low MCV equals microcytic, smaller RBCs
- High platelets equals reactive thrombocytosis
Why does it happen?
Iron deficiency or chronic blood loss stimulates the bone marrow. Since RBCs and platelets share precursor pathways, platelet production may rise while RBCs become smaller.
Clinical importance:
This pattern strongly supports iron deficiency anemia and helps differentiate it from many other anemias that do not typically present with both microcytosis plus thrombocytosis.
Important differential:
- Reactive (secondary) thrombocytosis – iron deficiency, infection, inflammation
- Primary (clonal) thrombocythemia – myeloproliferative disorders (e.g., JAK2 mutation)
Memory hook: Low MCV plus High Platelets, Think Iron Deficiency First.
References:
- Source: Williams Hematology and Harrison’s Principles of Internal Medicine.
- Key Concept: ‘Reactive Thrombocytosis in Iron Deficiency Anemia.’ – Dr. Sifat Jubaira MBBS, MPhil, MPH”
Find more posts featuring Sifat Jubaira on Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering